[HTML][HTML] Inhaled steroid/long-acting β2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients

J Lötvall, S Langley, A Woodcock - Respiratory research, 2006 - Springer
Background The combination of inhaled corticosteroids (ICS) and long-acting β2-agonists
(LABA) is recommended by treatment guidelines for the treatment of persistent asthma. Two …

Combination Inhalers Containing Inhaled Corticosteroids and Long-Acting β2-Agonists: Improved Clinical Efficacy and Dosing Options in Patients with Asthma

J Ankerst - Journal of Asthma, 2005 - Taylor & Francis
Combination therapy with inhaled corticosteroids (ICS) and long-acting β2-agonists (LABA)
is a recognized treatment for adults with moderate to severe asthma. The introduction of …

[HTML][HTML] Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice

M Tamm, DH Richards, B Beghé, L Fabbri - Respiratory medicine, 2012 - Elsevier
Fixed-dose combinations of inhaled corticosteroids (ICSs) and long-acting β2-agonists
(LABAs) have been used to manage asthma for several years. They are the preferred …

Clinical outcome of adding long-acting β-agonists to inhaled corticosteroids

PJ Barnes - Respiratory medicine, 2001 - Elsevier
Current asthma management guidelines state that where a patient is receiving a lowto
moderate dose of inhalated corticosteroids and is still experiencing symptoms the dose of …

Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma

DKC Lee, CM Jackson, GP Currie… - British journal of …, 2003 - Wiley Online Library
Aims Inhalers combining long acting β2‐adrenoceptor agonists (LABA) and corticosteroids
(ICS) are indicated at Step 3 of current asthma guidelines. We evaluated the relative effects …

Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: results from a 12-week randomized …

A Balki, S Balamurugan, S Bardapurkar, S Dalal… - Pulmonary …, 2018 - Elsevier
Background Combination therapy of inhaled corticosteroid/long acting β 2-agonist
(ICS/LABA) is the cornerstone of managing asthmatics who are uncontrolled with low …

Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged≥ 16 years with asthma: post hoc analysis of a randomized …

P Kuna - Clinical drug investigation, 2010 - Springer
Background Three fixed maintenance-dose inhaled corticosteroid/long-acting β 2-agonist
(ICS/LABA) combinations for the treatment of asthma are currently available …

Evaluation of combination long-acting β-2 agonists and inhaled glucocorticosteroids for treatment of asthma

D Kim, M Glaum, R Lockey - Expert Opinion on Drug Metabolism & …, 2009 - Taylor & Francis
Background: Treating asthma with a combination of inhaled corticosteroid and a long-acting
β-2-agonist is often preferred when asthma is not controlled when using a low-medium dose …

Combination therapy in asthma-fixed or variable dosing in different patients?

J Lötvall - Current medical research and opinion, 2004 - Taylor & Francis
The introduction of combination products, for the co-administration of an inhaled
corticosteroid (ICS) with a long-acting β2-agonist in a single inhaler, has greatly simplified …

Comparison of the effects of budesonide/formoterol maintenance and reliever therapy with fluticasone/salmeterol fixed-dose treatment on airway inflammation and …

S Hozawa, M Terada, M Hozawa - Pulmonary Pharmacology & …, 2014 - Elsevier
Background If asthma patients fail to achieve symptom control using a medium dose of
inhaled corticosteroid (ICS) alone, adding a long-acting β 2 agonist (LABA) is the preferred …